|
市場調査レポート
商品コード
1448088
男性型脱毛症の世界市場規模、シェアおよび動向分析レポート、治療別、性別別、販売チャネル別、地域別の見通しおよび予測、2023年～2030年Global Androgenetic Alopecia Market Size, Share & Trends Analysis Report By Treatment (Pharmaceuticals, and Devices), By Gender (Male, and Female), By Sales Channel, By Regional Outlook and Forecast, 2023 - 2030 |
||||||
|
|
|||||||
価格
| 男性型脱毛症の世界市場規模、シェアおよび動向分析レポート、治療別、性別別、販売チャネル別、地域別の見通しおよび予測、2023年～2030年 |
|
出版日: 2024年03月07日
発行: KBV Research
ページ情報: 英文 240 Pages
納期: 即納可能
 |
- 全表示
- 概要
- 図表
- 目次
概要
男性型脱毛症市場規模は2030年までに46億米ドルに達すると予想されており、予測期間中に8.1%のCAGRで市場成長が見込まれます。
さらに、アンドロゲン性脱毛症は、より高齢のグループでより一般的です。ホルモンの変化や毛包機能の低下など、加齢に伴う生理学的変化は、高齢者における脱毛の発生率の上昇に寄与しています。したがって、高齢者の数の増加は、市場の成長を推進する上で極めて重要な要因となっています。
市場ではサプライチェーンの混乱が発生し、医薬品、手術器具、その他の関連製品の入手可能性に影響が出る可能性があります。製造や流通の遅延は、治療や介入の提供に影響を与える可能性があります。非侵襲的で家庭的なソリューションが人気を集めました。このように、COVID-19感染症のパンデミックは市場に適度な影響を与えました。
しかし、治療費が高額であると、特に社会経済的地位が低い人や包括的な健康保険に加入していない人にとって、効果的な介入へのアクセスが制限される可能性があります。このアクセスの制限により、人口の大部分が高度な治療を受けることができなくなる可能性があります。したがって、一部の治療オプションのコストが高いと、市場の成長が鈍化する可能性があります。
目次
第1章 市場範囲と調査手法
- 市場の定義
- 目的
- 市場範囲
- セグメンテーション
- 調査手法
第2章 市場要覧
- 主なハイライト
第3章 市場概要
- イントロダクション
- 概要
- 市場構成とシナリオ
- 概要
- 市場に影響を与える主な要因
- 市場促進要因
- 市場抑制要因
- 市場機会
- 市場の課題
- ポーターファイブフォース分析
第4章 世界市場：治療別
- 世界の医薬品市場：地域別
- 世界のデバイス市場：地域別
第5章 世界市場：性別別
- 世界の男性市場：地域別
- 世界の女性市場：地域別
第6章 世界市場：販売チャネル別
- 世界の処方箋市場：地域別
- 世界のOTC市場：地域別
第7章 世界市場：最終用途別
- 世界の皮膚科クリニック市場：地域別
- 世界の在宅医療環境市場：地域別
第8章 世界市場：地域別
- 北米の市場
- 北米の市場治療別
- 北米の国別医薬品市場
- 北米の国別デバイス市場
- 北米の市場：性別別
- 北米の国別男性市場
- 北米の国別女性市場
- 北米の市場：販売チャネル別
- 北米の国別処方箋市場
- 北米の国別OTC市場
- 北米の市場：最終用途別
- 北米の国別皮膚科クリニック市場
- 北米の国別ホームケア環境市場
- 北米の市場：国別
- 米国の男性型脱毛症市場
- カナダの男性型脱毛症市場
- メキシコの男性型脱毛症市場
- その他の北米市場
- 北米の市場治療別
- 欧州の市場
- 欧州の市場治療別
- 欧州の国別医薬品市場
- 欧州の国別デバイス市場
- 欧州の市場：性別別
- 欧州の国別男性市場
- 欧州の国別女性市場
- 欧州の市場：販売チャネル別
- 欧州の国別処方箋市場
- 欧州の国別OTC市場
- 欧州の市場：最終用途別
- 欧州の国別皮膚科クリニック市場
- 欧州の国別ホームケア環境市場
- 欧州の市場：国別
- ドイツの男性型脱毛症市場
- 英国の男性型脱毛症市場
- フランスの男性型脱毛症市場
- ロシアの男性型脱毛症市場
- スペインの男性型脱毛症市場
- イタリアの男性型脱毛症市場
- その他の欧州市場
- 欧州の市場治療別
- アジア太平洋の市場
- アジア太平洋の市場治療別
- アジア太平洋の国別医薬品市場
- アジア太平洋の国別デバイス市場
- アジア太平洋の市場：性別別
- アジア太平洋の国別男性市場
- アジア太平洋の国別女性市場
- アジア太平洋の市場：販売チャネル別
- アジア太平洋の国別処方箋市場
- アジア太平洋の国別OTC市場
- アジア太平洋の市場：最終用途別
- アジア太平洋の国別皮膚科クリニック市場
- アジア太平洋の国別ホームケア環境市場
- アジア太平洋の市場：国別
- 中国男性型脱毛症市場
- 日本の男性型脱毛症市場
- インドの男性型脱毛症市場
- 韓国の男性型脱毛症市場
- オーストラリアの男性型脱毛症市場
- マレーシアの男性型脱毛症市場
- その他のアジア太平洋市場
- アジア太平洋の市場治療別
- ラテンアメリカ・中東・アフリカの市場
- ラテンアメリカ・中東・アフリカの市場治療別
- ラテンアメリカ・中東・アフリカの国別医薬品市場
- ラテンアメリカ・中東・アフリカの国別デバイス市場
- ラテンアメリカ・中東・アフリカの市場：性別別
- ラテンアメリカ・中東・アフリカの国別男性市場
- ラテンアメリカ・中東・アフリカの国別女性市場
- ラテンアメリカ・中東・アフリカの市場：販売チャネル別
- ラテンアメリカ・中東・アフリカの国別処方箋市場
- ラテンアメリカ・中東・アフリカの国別OTC市場
- ラテンアメリカ・中東・アフリカの市場：最終用途別
- ラテンアメリカ・中東・アフリカの国別皮膚科クリニック市場
- ラテンアメリカ・中東・アフリカの国別ホームケア設定市場
- ラテンアメリカ・中東・アフリカの市場：国別
- ブラジルの男性型脱毛症市場
- アルゼンチンの男性型脱毛症市場
- UAEの男性型脱毛症市場
- サウジアラビアの男性型脱毛症市場
- 南アフリカの男性型脱毛症市場
- ナイジェリアの男性型脱毛症市場
- その他のラテンアメリカ・中東・アフリカの市場
- ラテンアメリカ・中東・アフリカの市場治療別
第9章 企業プロファイル
- Cipla Limited
- Merck & Co, Inc.
- GlaxoSmithKline PLC（GSK）
- Sun Pharmaceuticals Industries Ltd
- Dr Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Pfizer, Inc
- Lutronic Co, Ltd.
- Viatris, Inc
- Eli Lilly And Company
第10章 男性型脱毛症市場の成功必須条件
図表
LIST OF TABLES
- TABLE 1Global Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 2Global Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 3Global Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 4Global Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 5Global Pharmaceuticals Market, By Region, 2019 - 2022, USD Million
- TABLE 6Global Pharmaceuticals Market, By Region, 2023 - 2030, USD Million
- TABLE 7Global Devices Market, By Region, 2019 - 2022, USD Million
- TABLE 8Global Devices Market, By Region, 2023 - 2030, USD Million
- TABLE 9Global Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 10Global Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 11Global Male Market, By Region, 2019 - 2022, USD Million
- TABLE 12Global Male Market, By Region, 2023 - 2030, USD Million
- TABLE 13Global Female Market, By Region, 2019 - 2022, USD Million
- TABLE 14Global Female Market, By Region, 2023 - 2030, USD Million
- TABLE 15Global Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 16Global Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 17Global Prescriptions Market, By Region, 2019 - 2022, USD Million
- TABLE 18Global Prescriptions Market, By Region, 2023 - 2030, USD Million
- TABLE 19Global OTC Market, By Region, 2019 - 2022, USD Million
- TABLE 20Global OTC Market, By Region, 2023 - 2030, USD Million
- TABLE 21Global Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 22Global Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 23Global Dermatology Clinics Market, By Region, 2019 - 2022, USD Million
- TABLE 24Global Dermatology Clinics Market, By Region, 2023 - 2030, USD Million
- TABLE 25Global Homecare Settings Market, By Region, 2019 - 2022, USD Million
- TABLE 26Global Homecare Settings Market, By Region, 2023 - 2030, USD Million
- TABLE 27Global Androgenetic Alopecia Market, By Region, 2019 - 2022, USD Million
- TABLE 28Global Androgenetic Alopecia Market, By Region, 2023 - 2030, USD Million
- TABLE 29North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 30North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 31North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 32North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 33North America Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
- TABLE 34North America Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
- TABLE 35North America Devices Market, By Country, 2019 - 2022, USD Million
- TABLE 36North America Devices Market, By Country, 2023 - 2030, USD Million
- TABLE 37North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 38North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 39North America Male Market, By Country, 2019 - 2022, USD Million
- TABLE 40North America Male Market, By Country, 2023 - 2030, USD Million
- TABLE 41North America Female Market, By Country, 2019 - 2022, USD Million
- TABLE 42North America Female Market, By Country, 2023 - 2030, USD Million
- TABLE 43North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 44North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 45North America Prescriptions Market, By Country, 2019 - 2022, USD Million
- TABLE 46North America Prescriptions Market, By Country, 2023 - 2030, USD Million
- TABLE 47North America OTC Market, By Country, 2019 - 2022, USD Million
- TABLE 48North America OTC Market, By Country, 2023 - 2030, USD Million
- TABLE 49North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 50North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 51North America Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
- TABLE 52North America Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
- TABLE 53North America Homecare Settings Market, By Country, 2019 - 2022, USD Million
- TABLE 54North America Homecare Settings Market, By Country, 2023 - 2030, USD Million
- TABLE 55North America Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
- TABLE 56North America Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
- TABLE 57US Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 58US Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 59US Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 60US Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 61US Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 62US Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 63US Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 64US Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 65US Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 66US Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 67Canada Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 68Canada Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 69Canada Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 70Canada Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 71Canada Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 72Canada Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 73Canada Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 74Canada Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 75Canada Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 76Canada Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 77Mexico Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 78Mexico Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 79Mexico Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 80Mexico Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 81Mexico Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 82Mexico Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 83Mexico Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 84Mexico Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 85Mexico Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 86Mexico Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 87Rest of North America Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 88Rest of North America Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 89Rest of North America Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 90Rest of North America Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 91Rest of North America Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 92Rest of North America Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 93Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 94Rest of North America Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 95Rest of North America Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 96Rest of North America Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 97Europe Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 98Europe Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 99Europe Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 100Europe Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 101Europe Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
- TABLE 102Europe Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
- TABLE 103Europe Devices Market, By Country, 2019 - 2022, USD Million
- TABLE 104Europe Devices Market, By Country, 2023 - 2030, USD Million
- TABLE 105Europe Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 106Europe Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 107Europe Male Market, By Country, 2019 - 2022, USD Million
- TABLE 108Europe Male Market, By Country, 2023 - 2030, USD Million
- TABLE 109Europe Female Market, By Country, 2019 - 2022, USD Million
- TABLE 110Europe Female Market, By Country, 2023 - 2030, USD Million
- TABLE 111Europe Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 112Europe Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 113Europe Prescriptions Market, By Country, 2019 - 2022, USD Million
- TABLE 114Europe Prescriptions Market, By Country, 2023 - 2030, USD Million
- TABLE 115Europe OTC Market, By Country, 2019 - 2022, USD Million
- TABLE 116Europe OTC Market, By Country, 2023 - 2030, USD Million
- TABLE 117Europe Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 118Europe Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 119Europe Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
- TABLE 120Europe Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
- TABLE 121Europe Homecare Settings Market, By Country, 2019 - 2022, USD Million
- TABLE 122Europe Homecare Settings Market, By Country, 2023 - 2030, USD Million
- TABLE 123Europe Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
- TABLE 124Europe Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
- TABLE 125Germany Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 126Germany Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 127Germany Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 128Germany Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 129Germany Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 130Germany Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 131Germany Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 132Germany Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 133Germany Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 134Germany Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 135UK Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 136UK Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 137UK Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 138UK Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 139UK Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 140UK Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 141UK Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 142UK Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 143UK Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 144UK Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 145France Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 146France Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 147France Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 148France Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 149France Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 150France Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 151France Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 152France Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 153France Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 154France Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 155Russia Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 156Russia Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 157Russia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 158Russia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 159Russia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 160Russia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 161Russia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 162Russia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 163Russia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 164Russia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 165Spain Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 166Spain Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 167Spain Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 168Spain Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 169Spain Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 170Spain Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 171Spain Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 172Spain Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 173Spain Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 174Spain Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 175Italy Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 176Italy Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 177Italy Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 178Italy Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 179Italy Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 180Italy Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 181Italy Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 182Italy Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 183Italy Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 184Italy Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 185Rest of Europe Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 186Rest of Europe Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 187Rest of Europe Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 188Rest of Europe Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 189Rest of Europe Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 190Rest of Europe Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 191Rest of Europe Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 192Rest of Europe Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 193Rest of Europe Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 194Rest of Europe Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 195Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 196Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 197Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 198Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 199Asia Pacific Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
- TABLE 200Asia Pacific Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
- TABLE 201Asia Pacific Devices Market, By Country, 2019 - 2022, USD Million
- TABLE 202Asia Pacific Devices Market, By Country, 2023 - 2030, USD Million
- TABLE 203Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 204Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 205Asia Pacific Male Market, By Country, 2019 - 2022, USD Million
- TABLE 206Asia Pacific Male Market, By Country, 2023 - 2030, USD Million
- TABLE 207Asia Pacific Female Market, By Country, 2019 - 2022, USD Million
- TABLE 208Asia Pacific Female Market, By Country, 2023 - 2030, USD Million
- TABLE 209Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 210Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 211Asia Pacific Prescriptions Market, By Country, 2019 - 2022, USD Million
- TABLE 212Asia Pacific Prescriptions Market, By Country, 2023 - 2030, USD Million
- TABLE 213Asia Pacific OTC Market, By Country, 2019 - 2022, USD Million
- TABLE 214Asia Pacific OTC Market, By Country, 2023 - 2030, USD Million
- TABLE 215Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 216Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 217Asia Pacific Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
- TABLE 218Asia Pacific Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
- TABLE 219Asia Pacific Homecare Settings Market, By Country, 2019 - 2022, USD Million
- TABLE 220Asia Pacific Homecare Settings Market, By Country, 2023 - 2030, USD Million
- TABLE 221Asia Pacific Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
- TABLE 222Asia Pacific Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
- TABLE 223China Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 224China Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 225China Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 226China Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 227China Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 228China Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 229China Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 230China Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 231China Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 232China Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 233Japan Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 234Japan Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 235Japan Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 236Japan Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 237Japan Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 238Japan Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 239Japan Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 240Japan Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 241Japan Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 242Japan Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 243India Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 244India Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 245India Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 246India Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 247India Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 248India Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 249India Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 250India Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 251India Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 252India Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 253South Korea Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 254South Korea Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 255South Korea Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 256South Korea Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 257South Korea Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 258South Korea Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 259South Korea Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 260South Korea Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 261South Korea Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 262South Korea Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 263Australia Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 264Australia Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 265Australia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 266Australia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 267Australia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 268Australia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 269Australia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 270Australia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 271Australia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 272Australia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 273Malaysia Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 274Malaysia Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 275Malaysia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 276Malaysia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 277Malaysia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 278Malaysia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 279Malaysia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 280Malaysia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 281Malaysia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 282Malaysia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 283Rest of Asia Pacific Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 284Rest of Asia Pacific Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 285Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 286Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 287Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 288Rest of Asia Pacific Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 289Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 290Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 291Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 292Rest of Asia Pacific Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 293LAMEA Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 294LAMEA Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 295LAMEA Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 296LAMEA Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 297LAMEA Pharmaceuticals Market, By Country, 2019 - 2022, USD Million
- TABLE 298LAMEA Pharmaceuticals Market, By Country, 2023 - 2030, USD Million
- TABLE 299LAMEA Devices Market, By Country, 2019 - 2022, USD Million
- TABLE 300LAMEA Devices Market, By Country, 2023 - 2030, USD Million
- TABLE 301LAMEA Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 302LAMEA Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 303LAMEA Male Market, By Country, 2019 - 2022, USD Million
- TABLE 304LAMEA Male Market, By Country, 2023 - 2030, USD Million
- TABLE 305LAMEA Female Market, By Country, 2019 - 2022, USD Million
- TABLE 306LAMEA Female Market, By Country, 2023 - 2030, USD Million
- TABLE 307LAMEA Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 308LAMEA Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 309LAMEA Prescriptions Market, By Country, 2019 - 2022, USD Million
- TABLE 310LAMEA Prescriptions Market, By Country, 2023 - 2030, USD Million
- TABLE 311LAMEA OTC Market, By Country, 2019 - 2022, USD Million
- TABLE 312LAMEA OTC Market, By Country, 2023 - 2030, USD Million
- TABLE 313LAMEA Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 314LAMEA Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 315LAMEA Dermatology Clinics Market, By Country, 2019 - 2022, USD Million
- TABLE 316LAMEA Dermatology Clinics Market, By Country, 2023 - 2030, USD Million
- TABLE 317LAMEA Homecare Settings Market, By Country, 2019 - 2022, USD Million
- TABLE 318LAMEA Homecare Settings Market, By Country, 2023 - 2030, USD Million
- TABLE 319LAMEA Androgenetic Alopecia Market, By Country, 2019 - 2022, USD Million
- TABLE 320LAMEA Androgenetic Alopecia Market, By Country, 2023 - 2030, USD Million
- TABLE 321Brazil Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 322Brazil Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 323Brazil Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 324Brazil Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 325Brazil Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 326Brazil Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 327Brazil Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 328Brazil Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 329Brazil Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 330Brazil Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 331Argentina Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 332Argentina Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 333Argentina Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 334Argentina Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 335Argentina Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 336Argentina Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 337Argentina Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 338Argentina Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 339Argentina Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 340Argentina Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 341UAE Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 342UAE Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 343UAE Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 344UAE Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 345UAE Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 346UAE Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 347UAE Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 348UAE Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 349UAE Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 350UAE Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 351Saudi Arabia Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 352Saudi Arabia Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 353Saudi Arabia Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 354Saudi Arabia Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 355Saudi Arabia Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 356Saudi Arabia Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 357Saudi Arabia Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 358Saudi Arabia Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 359Saudi Arabia Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 360Saudi Arabia Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 361South Africa Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 362South Africa Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 363South Africa Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 364South Africa Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 365South Africa Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 366South Africa Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 367South Africa Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 368South Africa Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 369South Africa Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 370South Africa Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 371Nigeria Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 372Nigeria Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 373Nigeria Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 374Nigeria Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 375Nigeria Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 376Nigeria Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 377Nigeria Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 378Nigeria Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 379Nigeria Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 380Nigeria Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 381Rest of LAMEA Androgenetic Alopecia Market, 2019 - 2022, USD Million
- TABLE 382Rest of LAMEA Androgenetic Alopecia Market, 2023 - 2030, USD Million
- TABLE 383Rest of LAMEA Androgenetic Alopecia Market, By Treatment, 2019 - 2022, USD Million
- TABLE 384Rest of LAMEA Androgenetic Alopecia Market, By Treatment, 2023 - 2030, USD Million
- TABLE 385Rest of LAMEA Androgenetic Alopecia Market, By Gender, 2019 - 2022, USD Million
- TABLE 386Rest of LAMEA Androgenetic Alopecia Market, By Gender, 2023 - 2030, USD Million
- TABLE 387Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel, 2019 - 2022, USD Million
- TABLE 388Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel, 2023 - 2030, USD Million
- TABLE 389Rest of LAMEA Androgenetic Alopecia Market, By End-use, 2019 - 2022, USD Million
- TABLE 390Rest of LAMEA Androgenetic Alopecia Market, By End-use, 2023 - 2030, USD Million
- TABLE 391Key Information - Cipla Limited
- TABLE 392Key Information - Merck & Co., Inc.
- TABLE 393Key Information - GlaxoSmithKline PLC
- TABLE 394Key Information - Sun Pharmaceuticals Industries Ltd.
- TABLE 395Key Information - Dr. Reddy's Laboratories Ltd.
- TABLE 396key information - Aurobindo Pharma Limited
- TABLE 397Key Information - Pfizer, Inc.
- TABLE 398Key Information - lUTRONIC cO., lTD.
- TABLE 399key information - Viatris, Inc.
- TABLE 400Key Information - Eli Lilly And Company
目次
The Global Androgenetic Alopecia Market size is expected to reach $4.6 billion by 2030, rising at a market growth of 8.1% CAGR during the forecast period.
Advancements in pharmaceutical R&D led to the discovery and development of innovative drugs for androgenetic alopecia. Therefore, the pharmaceuticals segment acquired $2,429.0 million revenue in 2022. New formulations and mechanisms of action expand the range of pharmaceutical options available to patients.
Cosmetic solutions are non-invasive and easy to use. Individuals can apply these products themselves, making them a convenient and user-friendly option for those who prefer non-surgical and non-pharmaceutical interventions. Thus, because of the increasing demand for cosmetic solutions, the market is anticipated to increase significantly.
Additionally, Androgenetic alopecia is more common in older age groups. The physiological changes associated with aging, such as hormonal shifts and reduced hair follicle function, contribute to a higher incidence of hair loss in the aging population. Hence, increasing number of senior citizens has been a pivotal factor in driving the growth of the market.
The market may experience disruptions in the supply chain, affecting the availability of pharmaceuticals, surgical instruments, and other related products. Delays in manufacturing and distribution can impact the delivery of treatments and interventions. Non-invasive and at-home solutions gained popularity. Thus, the COVID-19 pandemic had a moderate effect on the market.
However, High treatment costs may limit access to effective interventions, particularly for individuals with lower socioeconomic status or those without comprehensive health insurance coverage. This limited accessibility can result in a significant portion of the population being unable to afford advanced treatments. Thus, the high costs of some treatment options can slow down the growth of the market.
By Treatment Analysis
Based on treatment, the market is classified into pharmaceuticals and devices. The devices segment acquired a 3% revenue share in the market in 2022. The availability of devices for home use has expanded the reach of treatments. Home-use devices, such as laser caps and helmets, provide convenience for individuals seeking to address androgenetic alopecia in the comfort of their homes.
By Gender Analysis
By gender, the market is categorized into male and female. In 2022, the male segment acquired 70% revenue share in the market. Androgenetic alopecia is more prevalent in men than in women. As a result, men experiencing androgenetic alopecia may be more motivated to seek interventions to address hair loss, contributing to the uplift of the male segment in the market.
By Sales Channel Analysis
By sales channel, the market is segmented into prescriptions and OTC. The OTC segment recorded a remarkable 34% share in the market in 2022. The OTC segment offers a variety of products, including topical treatments, shampoos, supplements, and cosmetic solutions, providing consumers with diverse options to address their specific needs and preferences.
By End-use Analysis
On the basis of end-use, the market is divided into dermatology clinics and homecare settings. In 2022, the dermatology clinics segment dominated the market with 62.4% revenue share. These diagnostic tools help dermatologists accurately assess the severity and nature of androgenetic alopecia, guiding them in developing personalized treatment plans.
By Regional Analysis
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the 38.2% revenue share. In North America, individuals may start noticing hair loss in their 20s or 30s, increasing the risk.
List of Key Companies Profiled
- Cipla Limited
- Merck & Co., Inc.
- GlaxoSmithKline PLC (GSK)
- Sun Pharmaceuticals Industries Ltd.
- Dr. Reddy's Laboratories Ltd.
- Aurobindo Pharma Limited
- Pfizer, Inc.
- Lutronic Co., Ltd.
- Viatris Inc.
- Eli Lilly and Company
Global Androgenetic Alopecia Market Report Segmentation
By Treatment
- Pharmaceuticals
- Devices
By Gender
- Male
- Female
By Sales Channel
- Prescriptions
- OTC
By End-use
- Dermatology Clinics
- Homecare Settings
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Malaysia
- Rest of Asia Pacific
- LAMEA
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1Global Androgenetic Alopecia Market, by Treatment
- 1.4.2Global Androgenetic Alopecia Market, by Gender
- 1.4.3Global Androgenetic Alopecia Market, by Sales Channel
- 1.4.4Global Androgenetic Alopecia Market, by End-use
- 1.4.5Global Androgenetic Alopecia Market, by Geography
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Restraints
- 3.2.3Market Opportunities
- 3.2.4Market Challenges
- 3.3Porter Five Forces Analysis
Chapter 4.Global Androgenetic Alopecia Market, By Treatment
- 4.1Global Pharmaceuticals Market, By Region
- 4.2Global Devices Market, By Region
Chapter 5.Global Androgenetic Alopecia Market, By Gender
- 5.1Global Male Market, By Region
- 5.2Global Female Market, By Region
Chapter 6.Global Androgenetic Alopecia Market, By Sales Channel
- 6.1Global Prescriptions Market, By Region
- 6.2Global OTC Market, By Region
Chapter 7.Global Androgenetic Alopecia Market, By End-use
- 7.1Global Dermatology Clinics Market, By Region
- 7.2Global Homecare Settings Market, By Region
Chapter 8.Global Androgenetic Alopecia Market, By Region
- 8.1North America Androgenetic Alopecia Market
- 8.1.1North America Androgenetic Alopecia Market, By Treatment
- 8.1.1.1North America Pharmaceuticals Market, By Country
- 8.1.1.2North America Devices Market, By Country
- 8.1.2North America Androgenetic Alopecia Market, By Gender
- 8.1.2.1North America Male Market, By Country
- 8.1.2.2North America Female Market, By Country
- 8.1.3North America Androgenetic Alopecia Market, By Sales Channel
- 8.1.3.1North America Prescriptions Market, By Country
- 8.1.3.2North America OTC Market, By Country
- 8.1.4North America Androgenetic Alopecia Market, By End-use
- 8.1.4.1North America Dermatology Clinics Market, By Country
- 8.1.4.2North America Homecare Settings Market, By Country
- 8.1.5North America Androgenetic Alopecia Market, By Country
- 8.1.5.1US Androgenetic Alopecia Market
- 8.1.5.1.1US Androgenetic Alopecia Market, By Treatment
- 8.1.5.1.2US Androgenetic Alopecia Market, By Gender
- 8.1.5.1.3US Androgenetic Alopecia Market, By Sales Channel
- 8.1.5.1.4US Androgenetic Alopecia Market, By End-use
- 8.1.5.2Canada Androgenetic Alopecia Market
- 8.1.5.2.1Canada Androgenetic Alopecia Market, By Treatment
- 8.1.5.2.2Canada Androgenetic Alopecia Market, By Gender
- 8.1.5.2.3Canada Androgenetic Alopecia Market, By Sales Channel
- 8.1.5.2.4Canada Androgenetic Alopecia Market, By End-use
- 8.1.5.3Mexico Androgenetic Alopecia Market
- 8.1.5.3.1Mexico Androgenetic Alopecia Market, By Treatment
- 8.1.5.3.2Mexico Androgenetic Alopecia Market, By Gender
- 8.1.5.3.3Mexico Androgenetic Alopecia Market, By Sales Channel
- 8.1.5.3.4Mexico Androgenetic Alopecia Market, By End-use
- 8.1.5.4Rest of North America Androgenetic Alopecia Market
- 8.1.5.4.1Rest of North America Androgenetic Alopecia Market, By Treatment
- 8.1.5.4.2Rest of North America Androgenetic Alopecia Market, By Gender
- 8.1.5.4.3Rest of North America Androgenetic Alopecia Market, By Sales Channel
- 8.1.5.4.4Rest of North America Androgenetic Alopecia Market, By End-use
- 8.1.5.1US Androgenetic Alopecia Market
- 8.1.1North America Androgenetic Alopecia Market, By Treatment
- 8.2Europe Androgenetic Alopecia Market
- 8.2.1Europe Androgenetic Alopecia Market, By Treatment
- 8.2.1.1Europe Pharmaceuticals Market, By Country
- 8.2.1.2Europe Devices Market, By Country
- 8.2.2Europe Androgenetic Alopecia Market, By Gender
- 8.2.2.1Europe Male Market, By Country
- 8.2.2.2Europe Female Market, By Country
- 8.2.3Europe Androgenetic Alopecia Market, By Sales Channel
- 8.2.3.1Europe Prescriptions Market, By Country
- 8.2.3.2Europe OTC Market, By Country
- 8.2.4Europe Androgenetic Alopecia Market, By End-use
- 8.2.4.1Europe Dermatology Clinics Market, By Country
- 8.2.4.2Europe Homecare Settings Market, By Country
- 8.2.5Europe Androgenetic Alopecia Market, By Country
- 8.2.5.1Germany Androgenetic Alopecia Market
- 8.2.5.1.1Germany Androgenetic Alopecia Market, By Treatment
- 8.2.5.1.2Germany Androgenetic Alopecia Market, By Gender
- 8.2.5.1.3Germany Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.1.4Germany Androgenetic Alopecia Market, By End-use
- 8.2.5.2UK Androgenetic Alopecia Market
- 8.2.5.2.1UK Androgenetic Alopecia Market, By Treatment
- 8.2.5.2.2UK Androgenetic Alopecia Market, By Gender
- 8.2.5.2.3UK Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.2.4UK Androgenetic Alopecia Market, By End-use
- 8.2.5.3France Androgenetic Alopecia Market
- 8.2.5.3.1France Androgenetic Alopecia Market, By Treatment
- 8.2.5.3.2France Androgenetic Alopecia Market, By Gender
- 8.2.5.3.3France Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.3.4France Androgenetic Alopecia Market, By End-use
- 8.2.5.4Russia Androgenetic Alopecia Market
- 8.2.5.4.1Russia Androgenetic Alopecia Market, By Treatment
- 8.2.5.4.2Russia Androgenetic Alopecia Market, By Gender
- 8.2.5.4.3Russia Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.4.4Russia Androgenetic Alopecia Market, By End-use
- 8.2.5.5Spain Androgenetic Alopecia Market
- 8.2.5.5.1Spain Androgenetic Alopecia Market, By Treatment
- 8.2.5.5.2Spain Androgenetic Alopecia Market, By Gender
- 8.2.5.5.3Spain Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.5.4Spain Androgenetic Alopecia Market, By End-use
- 8.2.5.6Italy Androgenetic Alopecia Market
- 8.2.5.6.1Italy Androgenetic Alopecia Market, By Treatment
- 8.2.5.6.2Italy Androgenetic Alopecia Market, By Gender
- 8.2.5.6.3Italy Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.6.4Italy Androgenetic Alopecia Market, By End-use
- 8.2.5.7Rest of Europe Androgenetic Alopecia Market
- 8.2.5.7.1Rest of Europe Androgenetic Alopecia Market, By Treatment
- 8.2.5.7.2Rest of Europe Androgenetic Alopecia Market, By Gender
- 8.2.5.7.3Rest of Europe Androgenetic Alopecia Market, By Sales Channel
- 8.2.5.7.4Rest of Europe Androgenetic Alopecia Market, By End-use
- 8.2.5.1Germany Androgenetic Alopecia Market
- 8.2.1Europe Androgenetic Alopecia Market, By Treatment
- 8.3Asia Pacific Androgenetic Alopecia Market
- 8.3.1Asia Pacific Androgenetic Alopecia Market, By Treatment
- 8.3.1.1Asia Pacific Pharmaceuticals Market, By Country
- 8.3.1.2Asia Pacific Devices Market, By Country
- 8.3.2Asia Pacific Androgenetic Alopecia Market, By Gender
- 8.3.2.1Asia Pacific Male Market, By Country
- 8.3.2.2Asia Pacific Female Market, By Country
- 8.3.3Asia Pacific Androgenetic Alopecia Market, By Sales Channel
- 8.3.3.1Asia Pacific Prescriptions Market, By Country
- 8.3.3.2Asia Pacific OTC Market, By Country
- 8.3.4Asia Pacific Androgenetic Alopecia Market, By End-use
- 8.3.4.1Asia Pacific Dermatology Clinics Market, By Country
- 8.3.4.2Asia Pacific Homecare Settings Market, By Country
- 8.3.5Asia Pacific Androgenetic Alopecia Market, By Country
- 8.3.5.1China Androgenetic Alopecia Market
- 8.3.5.1.1China Androgenetic Alopecia Market, By Treatment
- 8.3.5.1.2China Androgenetic Alopecia Market, By Gender
- 8.3.5.1.3China Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.1.4China Androgenetic Alopecia Market, By End-use
- 8.3.5.2Japan Androgenetic Alopecia Market
- 8.3.5.2.1Japan Androgenetic Alopecia Market, By Treatment
- 8.3.5.2.2Japan Androgenetic Alopecia Market, By Gender
- 8.3.5.2.3Japan Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.2.4Japan Androgenetic Alopecia Market, By End-use
- 8.3.5.3India Androgenetic Alopecia Market
- 8.3.5.3.1India Androgenetic Alopecia Market, By Treatment
- 8.3.5.3.2India Androgenetic Alopecia Market, By Gender
- 8.3.5.3.3India Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.3.4India Androgenetic Alopecia Market, By End-use
- 8.3.5.4South Korea Androgenetic Alopecia Market
- 8.3.5.4.1South Korea Androgenetic Alopecia Market, By Treatment
- 8.3.5.4.2South Korea Androgenetic Alopecia Market, By Gender
- 8.3.5.4.3South Korea Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.4.4South Korea Androgenetic Alopecia Market, By End-use
- 8.3.5.5Australia Androgenetic Alopecia Market
- 8.3.5.5.1Australia Androgenetic Alopecia Market, By Treatment
- 8.3.5.5.2Australia Androgenetic Alopecia Market, By Gender
- 8.3.5.5.3Australia Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.5.4Australia Androgenetic Alopecia Market, By End-use
- 8.3.5.6Malaysia Androgenetic Alopecia Market
- 8.3.5.6.1Malaysia Androgenetic Alopecia Market, By Treatment
- 8.3.5.6.2Malaysia Androgenetic Alopecia Market, By Gender
- 8.3.5.6.3Malaysia Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.6.4Malaysia Androgenetic Alopecia Market, By End-use
- 8.3.5.7Rest of Asia Pacific Androgenetic Alopecia Market
- 8.3.5.7.1Rest of Asia Pacific Androgenetic Alopecia Market, By Treatment
- 8.3.5.7.2Rest of Asia Pacific Androgenetic Alopecia Market, By Gender
- 8.3.5.7.3Rest of Asia Pacific Androgenetic Alopecia Market, By Sales Channel
- 8.3.5.7.4Rest of Asia Pacific Androgenetic Alopecia Market, By End-use
- 8.3.5.1China Androgenetic Alopecia Market
- 8.3.1Asia Pacific Androgenetic Alopecia Market, By Treatment
- 8.4LAMEA Androgenetic Alopecia Market
- 8.4.1LAMEA Androgenetic Alopecia Market, By Treatment
- 8.4.1.1LAMEA Pharmaceuticals Market, By Country
- 8.4.1.2LAMEA Devices Market, By Country
- 8.4.2LAMEA Androgenetic Alopecia Market, By Gender
- 8.4.2.1LAMEA Male Market, By Country
- 8.4.2.2LAMEA Female Market, By Country
- 8.4.3LAMEA Androgenetic Alopecia Market, By Sales Channel
- 8.4.3.1LAMEA Prescriptions Market, By Country
- 8.4.3.2LAMEA OTC Market, By Country
- 8.4.4LAMEA Androgenetic Alopecia Market, By End-use
- 8.4.4.1LAMEA Dermatology Clinics Market, By Country
- 8.4.4.2LAMEA Homecare Settings Market, By Country
- 8.4.5LAMEA Androgenetic Alopecia Market, By Country
- 8.4.5.1Brazil Androgenetic Alopecia Market
- 8.4.5.1.1Brazil Androgenetic Alopecia Market, By Treatment
- 8.4.5.1.2Brazil Androgenetic Alopecia Market, By Gender
- 8.4.5.1.3Brazil Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.1.4Brazil Androgenetic Alopecia Market, By End-use
- 8.4.5.2Argentina Androgenetic Alopecia Market
- 8.4.5.2.1Argentina Androgenetic Alopecia Market, By Treatment
- 8.4.5.2.2Argentina Androgenetic Alopecia Market, By Gender
- 8.4.5.2.3Argentina Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.2.4Argentina Androgenetic Alopecia Market, By End-use
- 8.4.5.3UAE Androgenetic Alopecia Market
- 8.4.5.3.1UAE Androgenetic Alopecia Market, By Treatment
- 8.4.5.3.2UAE Androgenetic Alopecia Market, By Gender
- 8.4.5.3.3UAE Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.3.4UAE Androgenetic Alopecia Market, By End-use
- 8.4.5.4Saudi Arabia Androgenetic Alopecia Market
- 8.4.5.4.1Saudi Arabia Androgenetic Alopecia Market, By Treatment
- 8.4.5.4.2Saudi Arabia Androgenetic Alopecia Market, By Gender
- 8.4.5.4.3Saudi Arabia Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.4.4Saudi Arabia Androgenetic Alopecia Market, By End-use
- 8.4.5.5South Africa Androgenetic Alopecia Market
- 8.4.5.5.1South Africa Androgenetic Alopecia Market, By Treatment
- 8.4.5.5.2South Africa Androgenetic Alopecia Market, By Gender
- 8.4.5.5.3South Africa Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.5.4South Africa Androgenetic Alopecia Market, By End-use
- 8.4.5.6Nigeria Androgenetic Alopecia Market
- 8.4.5.6.1Nigeria Androgenetic Alopecia Market, By Treatment
- 8.4.5.6.2Nigeria Androgenetic Alopecia Market, By Gender
- 8.4.5.6.3Nigeria Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.6.4Nigeria Androgenetic Alopecia Market, By End-use
- 8.4.5.7Rest of LAMEA Androgenetic Alopecia Market
- 8.4.5.7.1Rest of LAMEA Androgenetic Alopecia Market, By Treatment
- 8.4.5.7.2Rest of LAMEA Androgenetic Alopecia Market, By Gender
- 8.4.5.7.3Rest of LAMEA Androgenetic Alopecia Market, By Sales Channel
- 8.4.5.7.4Rest of LAMEA Androgenetic Alopecia Market, By End-use
- 8.4.5.1Brazil Androgenetic Alopecia Market
- 8.4.1LAMEA Androgenetic Alopecia Market, By Treatment
Chapter 9.Company Profiles
- 9.1Cipla Limited
- 9.1.1Company Overview
- 9.1.2Financial Analysis
- 9.1.3Segmental and Regional Analysis
- 9.1.4Research & Development Expense
- 9.1.5SWOT Analysis
- 9.2Merck & Co., Inc.
- 9.2.1Company Overview
- 9.2.2Financial Analysis
- 9.2.3Segmental and Regional Analysis
- 9.2.4Research & Development Expenses
- 9.2.5SWOT Analysis
- 9.3GlaxoSmithKline PLC (GSK)
- 9.3.1Company Overview
- 9.3.2Financial Analysis
- 9.3.3Regional Analysis
- 9.3.4Research & Development Expense
- 9.3.5SWOT Analysis
- 9.4Sun Pharmaceuticals Industries Ltd.
- 9.4.1Company Overview
- 9.4.2Financial Analysis
- 9.4.3Regional Analysis
- 9.4.4Research & Development Expenses
- 9.4.5SWOT Analysis
- 9.5Dr. Reddy's Laboratories Ltd.
- 9.5.1Company Overview
- 9.5.2Financial Analysis
- 9.5.3Segmental and Regional Analysis
- 9.5.4Research & Development Expense
- 9.5.5Recent strategies and developments:
- 9.5.5.1Product Launches and Product Expansions:
- 9.5.6SWOT Analysis
- 9.6Aurobindo Pharma Limited
- 9.6.1Company Overview
- 9.6.2Financial Analysis
- 9.6.3Regional Analysis
- 9.6.4Research & Development Expense
- 9.6.5SWOT Analysis
- 9.7Pfizer, Inc.
- 9.7.1Company Overview
- 9.7.2Financial Analysis
- 9.7.3Regional & Segmental Analysis
- 9.7.4Research & Development Expense
- 9.7.5Recent strategies and developments:
- 9.7.5.1Trails and Approvals:
- 9.7.6SWOT Analysis
- 9.8Lutronic Co., Ltd.
- 9.8.1Company Overview
- 9.8.2Financial Analysis
- 9.8.3Regional Analysis
- 9.8.4Research & Development Expenses
- 9.8.5SWOT Analysis
- 9.9Viatris, Inc.
- 9.9.1Company Overview
- 9.9.2Financial Analysis
- 9.9.3Segmental Analysis
- 9.9.4Research & Development Expense
- 9.9.5SWOT Analysis
- 9.10.Eli Lilly And Company
- 9.10.1Company Overview
- 9.10.2Financial Analysis
- 9.10.3Regional Analysis
- 9.10.4Research & Development Expenses
- 9.10.5SWOT Analysis
